Intelligence · Clinical Pipeline
Gilead Sciences Pipeline
All ClinicalTrials.gov programs at Gilead Sciences — phase, modality, and trial IDs.
- Programs
- 3
Quick answer
Gilead Sciences has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
GS-5245 tablets 175 mg, GS-5245 tablets 350 mg
Gilead Sciences Pty Limited
Renal Impairment
1 trial -
Study of GS-0151 in Participants With Rheumatoid Arthritis
Gilead Sciences Pty Limited
Rheumatoid Arthritis
1 trial -
Study of GS-5319 in Adults With Solid Tumors
Gilead Sciences Pty Limited
Advanced solid tumors
1 trial
Frequently asked questions
How many pipeline programs does Gilead Sciences have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs